BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15147320)

  • 1. The basal ganglia network mediates the planning of movement amplitude.
    Desmurget M; Grafton ST; Vindras P; Gréa H; Turner RS
    Eur J Neurosci; 2004 May; 19(10):2871-80. PubMed ID: 15147320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint amplitude and connectivity compensatory mechanisms in Parkinson's disease.
    Palmer SJ; Li J; Wang ZJ; McKeown MJ
    Neuroscience; 2010 Apr; 166(4):1110-8. PubMed ID: 20074617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
    Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M
    Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal ganglia network mediates the control of movement amplitude.
    Desmurget M; Grafton ST; Vindras P; Gréa H; Turner RS
    Exp Brain Res; 2003 Nov; 153(2):197-209. PubMed ID: 13680045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional changes in the activity of cerebellum and frontostriatal regions during externally and internally timed movement in Parkinson's disease.
    Cerasa A; Hagberg GE; Peppe A; Bianciardi M; Gioia MC; Costa A; Castriota-Scanderbeg A; Caltagirone C; Sabatini U
    Brain Res Bull; 2006 Dec; 71(1-3):259-69. PubMed ID: 17113955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Movement precues in planning and execution of aiming movements in Parkinson's disease.
    Leis BC; Rand MK; Van Gemmert AW; Longstaff MG; Lou JS; Stelmach GE
    Exp Neurol; 2005 Aug; 194(2):393-409. PubMed ID: 16022867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysfunction of the basal ganglia, but not the cerebellum, impairs kinaesthesia.
    Maschke M; Gomez CM; Tuite PJ; Konczak J
    Brain; 2003 Oct; 126(Pt 10):2312-22. PubMed ID: 12821507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of saccades in Parkinson's disease.
    Armstrong IT; Chan F; Riopelle RJ; Munoz DP
    Brain Cogn; 2002 Jul; 49(2):198-201. PubMed ID: 15259388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface electromyography shows increased mirroring in Parkinson's disease patients without overt mirror movements.
    Cincotta M; Giovannelli F; Borgheresi A; Balestrieri F; Vanni P; Ragazzoni A; Zaccara G; Ziemann U
    Mov Disord; 2006 Sep; 21(9):1461-5. PubMed ID: 16705686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of disease progression and L-dopa therapy on the control of reaching-grasping in Parkinson's disease.
    Negrotti A; Secchi C; Gentilucci M
    Neuropsychologia; 2005; 43(3):450-9. PubMed ID: 15707620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the basal ganglia in category learning: how do patients with Parkinson's disease learn?
    Shohamy D; Myers CE; Onlaor S; Gluck MA
    Behav Neurosci; 2004 Aug; 118(4):676-86. PubMed ID: 15301595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The basal ganglia in Parkinson's disease: current concepts and unexplained observations.
    Obeso JA; Marin C; Rodriguez-Oroz C; Blesa J; Benitez-Temiño B; Mena-Segovia J; Rodríguez M; Olanow CW
    Ann Neurol; 2008 Dec; 64 Suppl 2():S30-46. PubMed ID: 19127584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the basal ganglia in the control of automatic visuospatial attention.
    Fielding J; Georgiou-Karistianis N; White O
    J Int Neuropsychol Soc; 2006 Sep; 12(5):657-67. PubMed ID: 16961947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional gait biomechanics in Parkinson's disease: evidence for a centrally mediated amplitude regulation disorder.
    Morris M; Iansek R; McGinley J; Matyas T; Huxham F
    Mov Disord; 2005 Jan; 20(1):40-50. PubMed ID: 15390033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal ganglia local field potential activity: character and functional significance in the human.
    Brown P; Williams D
    Clin Neurophysiol; 2005 Nov; 116(11):2510-9. PubMed ID: 16029963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged practice is of scarce benefit in improving motor performance in Parkinson's disease.
    Agostino R; Currà A; Soldati G; Dinapoli L; Chiacchiari L; Modugno N; Pierelli F; Berardelli A
    Mov Disord; 2004 Nov; 19(11):1285-93. PubMed ID: 15390058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subdural motor cortex stimulation in Parkinson's disease does not modify movement-related rCBF pattern.
    Strafella AP; Lozano AM; Lang AE; Ko JH; Poon YY; Moro E
    Mov Disord; 2007 Oct; 22(14):2113-6. PubMed ID: 17894326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Parkinson's disease and dopaminergic medication on proprioceptive processing.
    Mongeon D; Blanchet P; Messier J
    Neuroscience; 2009 Jan; 158(2):426-40. PubMed ID: 18996173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding Parkinsonian handwriting through a computational model of basal ganglia.
    Gangadhar G; Joseph D; Chakravarthy VS
    Neural Comput; 2008 Oct; 20(10):2491-525. PubMed ID: 18386983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supervisory and routine processes in noun and verb generation in nondemented patients with Parkinson's disease.
    Crescentini C; Mondolo F; Biasutti E; Shallice T
    Neuropsychologia; 2008 Jan; 46(2):434-47. PubMed ID: 17931671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.